Amir Tavakkol

Amir Tavakkol

Directeur Technique/Scientifique/R&D chez
Timber Pharmaceuticals LLC
71 ans
Health Technology
Consumer Services
Consumer Non-Durables

Profil

Amir Tavakkol currently works at Timber Pharmaceuticals LLC, as Chief Scientific Officer from 2019.
Dr. Tavakkol also formerly worked at Merck & Co., Inc., as Executive Director-Project Leadership, Schering-Plough Corp., as Senior Director, Novartis Pharmaceuticals Corp., as Clinical Director-Lamisil & Famvir, Colgate-Palmolive Co., as Principal, Viamet Pharmaceuticals, Inc., as Chief Development Officer from 2014 to 2017, the University of Michigan, as Professor-Dermatology Department, Topica Pharmaceuticals, Inc., as Senior VP-Clinical Development & Operations from 2011 to 2014, Castle Creek Biosciences, Inc., as Chief Development Officer from 2017 to 2018, and Timber Pharmaceuticals, Inc., as Chief Scientific Officer from 2020 to 2021.
Dr. Tavakkol received his doctorate degree in 1984 from The University of Manchester.

Postes actifs de Amir Tavakkol

SociétésPosteDébut
Directeur Technique/Scientifique/R&D 01/03/2019

Anciens postes connus de Amir Tavakkol

SociétésPosteFin
TREX WIND-DOWN, INC. Directeur Technique/Scientifique/R&D 04/02/2021
Corporate Officer/Principal 01/09/2018
Corporate Officer/Principal 01/10/2017
Directeur des opérations 01/07/2014
COLGATE-PALMOLIVE COMPANY Corporate Officer/Principal -
Voir l'expérience en détail de Amir Tavakkol

Formation de Amir Tavakkol

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

58

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Consumer Non-Durables

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Amir Tavakkol